+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmaceuticals Global Group of Eight (G8) Industry Guide 2014-2023

  • ID: 4771084
  • Report
  • April 2019
  • Region: Global
  • 209 pages
  • MarketLine
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 2
Pharmaceuticals Global Group of Eight (G8) Industry Guide 2014-2023

Summary

The G8 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Essential resource for top-line data and analysis covering the G8 pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights
  • The G8 countries contributed $682.6 billion in 2018 to the global pharmaceuticals industry, with a compound annual growth rate (CAGR) of 4% between 2014 and 2018. The G8 countries are expected to reach a value of $835.1 billion in 2023, with a CAGR of 4.1% over the 2018-23 period.
  • Among the G8 nations, the US is the leading country in the pharmaceuticals industry, with market revenues of $392.8 billion in 2018. This was followed by Germany and Japan, with a value of $78.0 and $70.9 billion, respectively.
  • The US is expected to lead the pharmaceuticals industry in the G8 nations with a value of $484.7 billion in 2016, followed by Germany and Japan with expected values of $99.0 and $79.4 billion, respectively.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players’ G8 operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the G8 pharmaceuticals market with five year forecasts
  • Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country
Reasons to buy
  • What was the size of the G8 pharmaceuticals market by value in 2018?
  • What will be the size of the G8 pharmaceuticals market in 2023?
  • What factors are affecting the strength of competition in the G8 pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the G8 pharmaceuticals market?
Note: Product cover images may vary from those shown
2 of 2
  • Introduction
  • What is this report about?
  • Who is the target reader?
  • How to use this report
  • Definitions
  • Group of Eight (G8) Pharmaceuticals
  • Industry Outlook
  • Pharmaceuticals in Canada
  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators
  • Pharmaceuticals in France
  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators
  • Pharmaceuticals in Germany
  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators
  • Pharmaceuticals in Italy
  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators
  • Pharmaceuticals in Japan
  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators
  • Pharmaceuticals in Russia
  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators
  • Pharmaceuticals in The United Kingdom
  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators
  • Pharmaceuticals in The United States
  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators
  • Company Profiles
  • Leading Companies
  • Appendix
  • Methodology
List Of Tables
Table 1: G8 pharmaceuticals industry, revenue($bn), 2014-23
Table 2: G8 pharmaceuticals industry, revenue by country ($bn), 2014-18
Table 3: G8 pharmaceuticals industry forecast, revenue by country ($bn), 2018-23
Table 4: Canada pharmaceuticals market value: $ billion, 2014-18
Table 5: Canada pharmaceuticals market geography segmentation: $ billion, 2018
Table 6: Canada pharmaceuticals market share: % share, by value, 2018
Table 7: Canada pharmaceuticals market value forecast: $ billion, 2018-23
Table 8: Canada size of population (million), 2014-18
Table 9: Canada gdp (constant 2005 prices, $ billion), 2014-18
Table 10: Canada gdp (current prices, $ billion), 2014-18
Table 11: Canada inflation, 2014-18
Table 12: Canada consumer price index (absolute), 2014-18
Table 13: Canada exchange rate, 2014-18
Table 14: France pharmaceuticals market value: $ billion, 2014-18
Table 15: France pharmaceuticals market geography segmentation: $ billion, 2018
Table 16: France pharmaceuticals market share: % share, by value, 2018
Table 17: France pharmaceuticals market value forecast: $ billion, 2018-23
Table 18: France size of population (million), 2014-18
Table 19: France gdp (constant 2005 prices, $ billion), 2014-18
Table 20: France gdp (current prices, $ billion), 2014-18
Table 21: France inflation, 2014-18
Table 22: France consumer price index (absolute), 2014-18
Table 23: France exchange rate, 2014-18
Table 24: Germany pharmaceuticals market value: $ billion, 2014-18
Table 25: Germany pharmaceuticals market geography segmentation: $ billion, 2018
Table 26: Germany pharmaceuticals market share: % share, by value, 2018
Table 27: Germany pharmaceuticals market value forecast: $ billion, 2018-23
Table 28: Germany size of population (million), 2014-18
Table 29: Germany gdp (constant 2005 prices, $ billion), 2014-18
Table 30: Germany gdp (current prices, $ billion), 2014-18
Table 31: Germany inflation, 2014-18
Table 32: Germany consumer price index (absolute), 2014-18
Table 33: Germany exchange rate, 2014-18
Table 34: Italy pharmaceuticals market value: $ billion, 2014-18
Table 35: Italy pharmaceuticals market geography segmentation: $ billion, 2018
Table 36: Italy pharmaceuticals market share: % share, by value, 2018
Table 37: Italy pharmaceuticals market value forecast: $ billion, 2018-23
Table 38: Italy size of population (million), 2014-18
Table 39: Italy gdp (constant 2005 prices, $ billion), 2014-18
Table 40: Italy gdp (current prices, $ billion), 2014-18
Table 41: Italy inflation, 2014-18
Table 42: Italy consumer price index (absolute), 2014-18
Table 43: Italy exchange rate, 2014-18
Table 44: Japan pharmaceuticals market value: $ billion, 2014-18
Table 45: Japan pharmaceuticals market geography segmentation: $ billion, 2018
Table 46: Japan pharmaceuticals market share: % share, by value, 2018
Table 47: Japan pharmaceuticals market value forecast: $ billion, 2018-23
Table 48: Japan size of population (million), 2014-18
Table 49: Japan gdp (constant 2005 prices, $ billion), 2014-18
Table 50: Japan gdp (current prices, $ billion), 2014-18
Table 51: Japan inflation, 2014-18
Table 52: Japan consumer price index (absolute), 2014-18
Table 53: Japan exchange rate, 2014-18
Table 54: Russia pharmaceuticals market value: $ billion, 2014-18
Table 55: Russia pharmaceuticals market geography segmentation: $ billion, 2018
Table 56: Russia pharmaceuticals market share: % share, by value, 2018
Table 57: Russia pharmaceuticals market value forecast: $ billion, 2018-23
Table 58: Russia size of population (million), 2014-18
Table 59: Russia gdp (constant 2005 prices, $ billion), 2014-18
Table 60: Russia gdp (current prices, $ billion), 2014-18

List of Figures
Figure 1: G8 pharmaceuticals industry, revenue($bn), 2014-23
Figure 2: G8 Pharmaceuticals industry, revenue by country (%), 2018
Figure 3: G8 pharmaceuticals industry, revenue by country ($bn), 2014-18
Figure 4: G8 pharmaceuticals industry forecast, revenue by country ($bn), 2018-23
Figure 5: Canada pharmaceuticals market value: $ billion, 2014-18
Figure 6: Canada pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 7: Canada pharmaceuticals market share: % share, by value, 2018
Figure 8: Canada pharmaceuticals market value forecast: $ billion, 2018-23
Figure 9: Forces driving competition in the pharmaceuticals market in Canada, 2018
Figure 10: Drivers of buyer power in the pharmaceuticals market in Canada, 2018
Figure 11: Drivers of supplier power in the pharmaceuticals market in Canada, 2018
Figure 12: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2018
Figure 13: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2018
Figure 14: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2018
Figure 15: France pharmaceuticals market value: $ billion, 2014-18
Figure 16: France pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 17: France pharmaceuticals market share: % share, by value, 2018
Figure 18: France pharmaceuticals market value forecast: $ billion, 2018-23
Figure 19: Forces driving competition in the pharmaceuticals market in France, 2018
Figure 20: Drivers of buyer power in the pharmaceuticals market in France, 2018
Figure 21: Drivers of supplier power in the pharmaceuticals market in France, 2018
Figure 22: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2018
Figure 23: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2018
Figure 24: Drivers of degree of rivalry in the pharmaceuticals market in France, 2018
Figure 25: Germany pharmaceuticals market value: $ billion, 2014-18
Figure 26: Germany pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 27: Germany pharmaceuticals market share: % share, by value, 2018
Figure 28: Germany pharmaceuticals market value forecast: $ billion, 2018-23
Figure 29: Forces driving competition in the pharmaceuticals market in Germany, 2018
Figure 30: Drivers of buyer power in the pharmaceuticals market in Germany, 2018
Figure 31: Drivers of supplier power in the pharmaceuticals market in Germany, 2018
Figure 32: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2018
Figure 33: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2018
Figure 34: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2018
Figure 35: Italy pharmaceuticals market value: $ billion, 2014-18
Figure 36: Italy pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 37: Italy pharmaceuticals market share: % share, by value, 2018
Figure 38: Italy pharmaceuticals market value forecast: $ billion, 2018-23
Figure 39: Forces driving competition in the pharmaceuticals market in Italy, 2018
Figure 40: Drivers of buyer power in the pharmaceuticals market in Italy, 2018
Figure 41: Drivers of supplier power in the pharmaceuticals market in Italy, 2018
Figure 42: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2018
Figure 43: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2018
Figure 44: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2018
Figure 45: Japan pharmaceuticals market value: $ billion, 2014-18
Figure 46: Japan pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 47: Japan pharmaceuticals market share: % share, by value, 2018
Figure 48: Japan pharmaceuticals market value forecast: $ billion, 2018-23
Figure 49: Forces driving competition in the pharmaceuticals market in Japan, 2018
Figure 50: Drivers of buyer power in the pharmaceuticals market in Japan, 2018
Figure 51: Drivers of supplier power in the pharmaceuticals market in Japan, 2018
Figure 52: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2018
Figure 53: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2018
Figure 54: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2018
Figure 55: Russia pharmaceuticals market value: $ billion, 2014-18
Figure 56: Russia pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 57: Russia pharmaceuticals market share: % share, by value, 2018
Figure 58: Russia pharmaceuticals market value forecast: $ billion, 2018-23
Figure 59: Forces driving competition in the pharmaceuticals market in Russia, 2018
Figure 60: Drivers of buyer power in the pharmaceuticals market in Russia, 2018
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll